Video-capsule manufacturer Given Imaging of Yoqneam, Israel, said it has received reimbursement approval from Australia’s Medical Services Advisory Committee for the use of its M2A capsule endoscope. The product is approved for use in cases of obscure gastrointestinal bleeding in patients following previous colonoscopy and upper gastrointestinal endoscopy without identifying the bleeding source.
By AuntMinnie.com staff writers
September 18, 2003
Related Reading
Given Imaging receives FDA first-line tool clearance, July 8, 2003
Given Imaging gets Israeli reimbursement, July 3, 2003
Given Imaging increases revenues, trims loss, May 2, 2003
Aetna adds Given Imaging to reimbursement list, April 29, 2003
Given Imaging releases early Q1 revenues, April 3, 2003
Copyright © 2003 AuntMinnie.com
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&dpr=2&fit=crop&h=167&q=70&w=250)
